Protonix
Product Images NDC 67296-0029

8 FDA label images from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 67296-0029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Redpharm (67296 0029)

Redpharm (67296 0029)
Label for Protonix 40mg tablets, quantity of 14, with NDC 67296-0029. The label indicates prescription only (Rx Only), lot number 7172ANX1, and expiration date 10/23. Manufacturer listed as Wyeth Pharmaceuticals LLC, Philadelphia, PA. Distributed by Redpharm Drug, Eden Prairie, MN.*
FDA Label Image

Chemical Structure (Protonix 01)

Chemical Structure (Protonix 01)
Chemical structure of the active ingredient in Protonix Delayed-Release, showing a complex heterocyclic molecule with sodium salt and hydrated form (1.5 H2O).*
FDA Label Image

Pfizer Logo (Protonix 02)

FDA Label Image

Pfizer Logo (Protonix 03)

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Principal Display Panel (20 mg Tablet Bottle Label)
Protonix Delayed-Release 20 mg tablets label by RedPharm Drug, Inc. The label shows 90 tablets with instructions to swallow whole without splitting, chewing, or crushing. Active ingredient is pantoprazole sodium. Packaging includes a barcode, manufacturer details, and notes on storage temperature.*
FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Principal Display Panel (40 mg Tablet Bottle Label)
Packaging label for Protonix delayed-release tablets, containing 40 mg of pantoprazole sodium. The label includes a dosage instruction to swallow tablets whole without splitting, chewing, or crushing. The package contains 90 tablets. It shows Pfizer branding and states the product is Rx only. Additional data includes storage instructions and distributor information, along with various codes and a QR code.*
FDA Label Image

Principal Display Panel (40 mg Packet)

Principal Display Panel (40 mg Packet)
Packaging label for Protonix 40 mg delayed-release oral suspension by Pfizer. The label specifies pantoprazole sodium as the active ingredient and includes instructions for suspension in apple juice or applesauce. The label also shows a barcode, NDC 0008-0844-01, and references for storage and dosage information.*
FDA Label Image

Principal Display Panel (40 mg Packet Carton)

Principal Display Panel (40 mg Packet Carton)
Box packaging for Protonix Delayed-Release 40 mg oral suspension packets by RedPharm Drug, Inc. The label includes the Pfizer and Wyeth logos, indicates the active ingredient as pantoprazole sodium, and specifies 30 packets per box. Instructions warn to always dispense with medication guide and detail administration in apple juice or applesauce only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.